These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 155862)

  • 41. Stimulation single fiber EMG study in patients receiving a long-term D-penicillamine treatment for rheumatoid arthritis.
    Dominkus M; Grisold W; Albrecht G
    Muscle Nerve; 1992 Nov; 15(11):1300-1. PubMed ID: 1488070
    [No Abstract]   [Full Text] [Related]  

  • 42. [Minimal changes nephrotic syndrome associated to penicillamine treatment].
    Basterrechea MA; de Arriba G; García-Martín F; Sánchez-Heras M; Giménez-Vega E; Sánchez J
    Nefrologia; 2004; 24(2):183-7. PubMed ID: 15219094
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [A case of rheumatoid arthritis associated with leukocytopenia during D-penicillamine treatment].
    Negishi M; Sato H; Sekine F; Mita S; Ono I; Kobayashi K; Oseto Y; Hamai T; Takahashi T
    Arerugi; 1982 Jun; 31(6):350-4. PubMed ID: 7181659
    [No Abstract]   [Full Text] [Related]  

  • 44. Gold vs D-penicillamine double blind study and followup.
    Thomas MH; Rothermich NO; Philips VK; Bergen W; Hedrick SW
    J Rheumatol; 1984 Dec; 11(6):764-7. PubMed ID: 6240537
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Longterm followup of treatment with D-penicillamine for rheumatoid arthritis: effectivity and toxicity in relation to HLA antigens.
    Moens HJ; Ament BJ; Feltkamp BW; van der Korst JK
    J Rheumatol; 1987 Dec; 14(6):1115-9. PubMed ID: 3437418
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical evaluation of D-penicillamine by multicentric double-blind comparative study in chronic rheumatoid arthritis.
    Shiokawa Y; Horiuchi Y; Honma M; Kageyama T; Okada T; Azuma T
    Arthritis Rheum; 1977; 20(8):1464-72. PubMed ID: 144507
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [3 years of penicillamine D therapy of 100 patients with rheumatoid polyarthritis].
    Santamaria A; Ruíz de La Torre R; Barceló P; Ripoll M; Escarpenter J; Barceló P
    Rev Esp Reum Enferm Osteoartic; 1977; 20(4):335-8. PubMed ID: 341244
    [No Abstract]   [Full Text] [Related]  

  • 48. [The failures of D penicillamine].
    Ayrolles C; Guyard C; Fournié A
    Rev Rhum Mal Osteoartic; 1978 Mar; 45(3):161-4. PubMed ID: 653292
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Penicillamine nephropathy].
    Henningsen B; Maintz J; Buchholz K; Harders H
    ZFA (Stuttgart); 1976 Jan; 52(2):77-9. PubMed ID: 1266313
    [No Abstract]   [Full Text] [Related]  

  • 50. [Chlorbutin, azathioprine, D-penicillamine, and levamisole (Decaris) in the treatment of rheumatoid arthritis patients. I. Comparative analysis of side effects].
    Krel' AA; Kanevskaia MZ; Rashchupkina ZP; Bolotin EV; Chichasova NV
    Ter Arkh; 1981; 53(7):86-96. PubMed ID: 6457409
    [No Abstract]   [Full Text] [Related]  

  • 51. [The basal therapy of rheumatoid arthritis with d-penicillamine (author's transl)].
    Waskönig FW; Meyer W
    Munch Med Wochenschr; 1973 Nov; 115(45):2047-50. PubMed ID: 4801138
    [No Abstract]   [Full Text] [Related]  

  • 52. The side effects of penicillamine therapy in rheumatoid arthritis.
    Huskisson EC
    J Rheumatol Suppl; 1981; 7():146-8. PubMed ID: 6939876
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Results of Cuprenil (D-penicillamine) treatment in patients with rheumatoid arthritis].
    Maldykowa H; Chwalińska-Sadowska H; Luft S; Glińska-Urban D; Mikolajew M; Odrzywolska A; Jaworska H
    Reumatologia; 1972; 10(1):9-21. PubMed ID: 5019762
    [No Abstract]   [Full Text] [Related]  

  • 54. IgM nephropathy associated with penicillamine.
    Rehan A; Johnson K
    Am J Nephrol; 1986; 6(1):71-4. PubMed ID: 3963062
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prior gold therapy does not influence the adverse effects of D-penicillamine in rheumatoid arthritis.
    Kean WF; Lock CJ; Howard-Lock HE; Buchanan WW
    Arthritis Rheum; 1982 Aug; 25(8):917-22. PubMed ID: 6214261
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [D-penicillamine and steroids in the treatment of rheumatoid arthritis].
    Rudy J; Sarosiek J
    Wiad Lek; 1978 Apr; 31(7):449-55. PubMed ID: 664674
    [No Abstract]   [Full Text] [Related]  

  • 57. [Treatment of rheumatoid arthritis with kuprenyl (D-penicillamine)].
    Maldyk G; Khvalińska-Sadovska A
    Ter Arkh; 1975; 47(11):107-8. PubMed ID: 1224291
    [No Abstract]   [Full Text] [Related]  

  • 58. Side-effects of long-term D-penicillamine therapy in rheumatoid arthritis.
    Perl S
    S Afr Med J; 1977 Oct; 52(18):710. PubMed ID: 146263
    [No Abstract]   [Full Text] [Related]  

  • 59. [Direct, immediate and late results of the treatment of rheumatoid arthritis with D-penicillamine].
    Matveĭkov GP; Zhivutskiĭ II; Koshelev VK; Pshonik SS
    Vopr Revm; 1978; (4):6-12. PubMed ID: 364835
    [No Abstract]   [Full Text] [Related]  

  • 60. Controlled trial of D(-)penicillamine in severe rheumatoid arthritis.
    Lancet; 1973 Feb; 1(7798):275-80. PubMed ID: 4119168
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.